Medicure (MCUJF) Depreciation & Amortization (CF) (2009 - 2026)
Medicure (MCUJF) posted quarterly Depreciation & Amortization (CF) of $75108.2 for Q1 2026, down 5.46% year-over-year from $79448.5 in Q1 2025, and down 13.44% quarter-over-quarter from $86767.4 in Q4 2025.
Medicure (MCUJF) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Medicure's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $75108.2 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 5.46% year-over-year to $75108.2; the TTM figure through Mar 2026 stood at $349478.5 (up 8.5% YoY), while the FY2025 annual figure was $353566.4, up 10.52% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $75108.2, down from $86767.4 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $262994.0 in Q3 2022, with the low at $70863.4 in Q3 2023.
- The 5-year median for Depreciation & Amortization (CF) is $84019.8 (2023), against an average of $99790.5.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) soared 244.85% in 2022, then plunged 73.06% in 2023.
- Medicure's Depreciation & Amortization (CF) stood at $262994.0 in 2022, then sank by 67.88% to $84471.6 in 2023, then retreated by 2.54% to $82322.7 in 2024, then grew by 5.4% to $86767.4 in 2025, then slipped by 13.44% to $75108.2 in 2026.
- Business Quant data shows MCUJF's Depreciation & Amortization (CF) at $75108.2 in Q1 2026, $86767.4 in Q4 2025, and $100275.6 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | 75,108.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75,108.19 |
| Mar 31, 2026 | 75,108.19 |
| Dec 31, 2025 | 86,767.44 |
| Dec 31, 2025 | 86,767.44 |
| Sep 30, 2025 | 100,275.63 |
| Sep 30, 2025 | 100,275.63 |
| Jun 30, 2025 | 87,327.21 |
| Jun 30, 2025 | 87,327.21 |
| Mar 31, 2025 | 79,448.48 |
| Mar 31, 2025 | 79,448.48 |
| Dec 31, 2024 | 82,322.65 |
| Dec 31, 2024 | 82,322.65 |
| Sep 30, 2024 | 83,568.09 |
| Sep 30, 2024 | 83,568.09 |
| Jun 30, 2024 | 76,769.76 |
| Jun 30, 2024 | 76,769.76 |
| Mar 31, 2024 | 77,179.77 |
| Mar 31, 2024 | 77,179.77 |
| Dec 31, 2023 | 84,471.59 |
| Dec 31, 2023 | 84,471.59 |